Pelvic MRI, FDG-PET/CT, and Somatostatin Receptor Scintigraphy Findings of Treatment-Related Neuroendocrine-Differentiated Prostate Cancer

Pelvic MRI, FDG-PET/CT, and Somatostatin Receptor Scintigraphy Findings of Treatment-Related Neuroendocrine-Differentiated Prostate Cancer

Treatment-related neuroendocrine-differentiated prostate cancer (NEPC) is a rare tumor entity that transdifferentiates from adenocarcinoma as an adaptive response to androgen receptor pathway inhibition. We report a 79-year-old male with treatment-related NEPC, presenting as rectal bleeding after ho...

Full description

Bibliographic Details
Main Authors: Kazuhiro Kitajima, Shingo Yamamoto, Masataka Ikeda, Takashi Yamasaki, Yusuke Kawanaka, Hisashi Komoto, Mitsunari Maruyama, Kosuke Nishizaki, Kei Kimura, Neinei Kimura, Koichiro Yamakado
Format: Article
Language:English
Published: Karger Publishers 2021-03-01
Series:Case Reports in Oncology
Subjects:
neuroendocrine differentiation
prostate cancer
mri
fdg-pet/ct
somatostatin receptor scintigraphy
Online Access:http://prod.karger.com/Article/FullText/511070

Internet

http://prod.karger.com/Article/FullText/511070

Similar Items